No black box warning on record for Propranolol Hydrochloride

As of the latest FDA labeling reviewed, Propranolol Hydrochloride (PROPRANOLOL HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Propranolol Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Angina Pectoris There have been reports of exacerbation of angina and, in some cases, myocardial infarction, following abrupt discontinuance of propranolol therapy. Therefore, when discontinuance of propranolol is planned, the dosage should be gradually reduced over at least a few weeks and the patient should be cautioned against interruption or cessation of therapy without the physician’

No black box warning on record for Propranolol Hydrochloride

Other warnings & precautions

WARNINGS Angina Pectoris There have been reports of exacerbation of angina and, in some cases, myocardial infarction, following abrupt discontinuance of propranolol therapy. Therefore, when discontinuance of propranolol is planned, the dosage should be gradually reduced over at least a few weeks and the patient should be cautioned against interruption or cessation of therapy without the physician’

Propranolol Hydrochloride Black Box Warning

No black box warning on record for Propranolol Hydrochloride

Other warnings & precautions

Propranolol Hydrochloride Black Box Warning

No black box warning on record for Propranolol Hydrochloride

Other warnings & precautions